Acquisition by Bell John Irving of 14534 shares of Immunocore Holdings at 50.47 subject to Rule 16b-3

IMCR Stock  USD 32.12  0.30  0.93%   
Slightly above 55% of Immunocore Holdings' investor base is interested to short. The analysis of the overall investor sentiment regarding Immunocore Holdings suggests that many traders are impartial. Immunocore Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Immunocore Holdings. Many technical investors use Immunocore Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Immunocore Holdings Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 14534 share option (right to buy) at 50.47 of Immunocore Holdings by Bell John Irving on 23rd of May 2024. This event was filed by Immunocore Holdings with SEC on 2024-05-23. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Immunocore Holdings' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Immunocore Holdings' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Immunocore Holdings Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Immunocore Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Immunocore Holdings Historical Investor Sentiment

Investor biases related to Immunocore Holdings' public news can be used to forecast risks associated with an investment in Immunocore. The trend in average sentiment can be used to explain how an investor holding Immunocore can time the market purely based on public headlines and social activities around Immunocore Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunocore Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunocore Holdings and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Immunocore Holdings news discussions. The higher the estimate score, the more favorable the investor's outlook on Immunocore Holdings.

Immunocore Holdings Fundamental Analysis

We analyze Immunocore Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunocore Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunocore Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Immunocore Holdings is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Immunocore Holdings Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunocore Holdings stock to make a market-neutral strategy. Peer analysis of Immunocore Holdings could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with similar companies.

Peers

Immunocore Holdings Related Equities

ERASErasca   7.69   
0%
76.0%
KALVKalvista Pharmaceuticals   4.02   
0%
40.0%
NUVLNuvalent   2.45   
0%
24.0%
DSGNDesign Therapeutics   1.64   
0%
16.0%
PCVXVaxcyte   1.14   
0%
11.0%
LRMRLarimar Therapeutics   0.82   
0%
8.0%
VTYXVentyx Biosciences   0.58   
0%
5.0%
GLUEMonte Rosa   0.12   
1.0%
0%
ACLXArcellx   0.42   
4.0%
0%
MIRMMirum Pharmaceuticals   0.48   
4.0%
0%
VRDNViridian Therapeutics   0.86   
8.0%
0%
LYRALyra Therapeutics   10.00   
100.0%
0%

Additional Tools for Immunocore Stock Analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.